Signaling Pathways - Hepatocellular Carcinoma - Type 2 Diabetes - Colon Cancer - Multidrug Resistance Studies
清除全部
-
B6032 CB-5083Target: p97Summary: p97抑制剂 -
B4763 GKT1378311 CitationTarget: NADPH OxidasesSummary: Nox1/Nox4双重抑制剂 -
B3272 InauhzinTarget: Sir2-like Family Deacetylases (Sirtuins)Summary: SIRT1抑制剂 -
B5979 CCT251545Summary: WNT信号的具有口服生物利用度的有效抑制剂 -
B4794 Santacruzamate A (CAY10683)Target: Histone Deacetylases (HDACs)Summary: HDAC抑制剂 -
B7794 BMS 3094032 CitationTarget: Fatty-acid-binding proteins (FABPs)Summary: FABP4抑制剂 -
B5612 BAY 60-6583Target: Adenosine A2B ReceptorsSummary: A2B受体的强效激动剂 -
B7641 YC 1中文名: 利非西呱Target: Guanylyl CyclasesSummary: 可溶性鸟苷酸环化酶（sGC）激活剂 -
B6766 CL 316243 disodium saltSummary: 鼠选择性的β3肾上腺素受体激动剂 -
B1410 Amlodipine中文名: 氨氯地平Target: Voltage-gated Calcium Channels (CaV)Summary: 钙通道阻滞剂